Elicio Therapeutics, Inc. (ELTX)

NCM – Real Time Price. Currency in USD

10.41

-0.14 (-1.33%)

Market open: May 13, 2026, 9:32 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-1M

Gross Profit

-1M

Operating expenses (excl. COGS)

-37M

-44M

-35M

-23M

Operating Income

-38M

-45M

-36M

-24M

Non-operating income, total

-2M

-7M

550K

-4M

Pretax income

-40M

-52M

-35M

-28M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-40M

-52M

-35M

-28M

Elicio Therapeutics, Inc. (ELTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Elicio Therapeutics, Inc. (ELTX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Elicio Therapeutics, Inc. (ELTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Elicio Therapeutics, Inc. (ELTX)

Income Statement (Annual)

Income Statement (Annual)